Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C known ✓ | P28335 | 2/20 | 0.68 |
| ▸ | HTR2B known ✓ | P41595 | 2/20 | 0.68 |
| ▸ | KCNH2 known ✓ | Q12809 | 2/20 | 0.68 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.68 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.68 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.68 |
| ▸ | DRD2 known ✓ | P14416 | 10/20 | 0.55 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.46 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 11/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.68 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | HTR1A | P08908 | 1/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL7368627 | 1.00 | DRD3 (0.68) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| SCHEMBL7373070 | 0.95 | DRD3 (0.74) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| SCHEMBL3361901 | 0.89 | DRD3 (0.85) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| SCHEMBL7364946 | 0.88 | KCNH2 (0.88) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| SCHEMBL7366214 | 0.88 | DRD3 (0.70) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| Fumaric Acid SCHEMBL7372960 | 0.86 | DRD3 (0.70) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| Fumaric Acid SCHEMBL7372963 | 0.86 | DRD3 (0.70) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| SCHEMBL1502026 | 0.86 | DRD4 (0.73) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| SCHEMBL7370549 | 0.85 | DRD3 (0.69) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 | |
| SCHEMBL7369773 | 0.84 | DRD3 (0.77) | DRD3CYP3A4CYP1A2ADRA2ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0243959-B1 | SUBSTITUTED BENZAMIDE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Dainippon Pharmaceutical Co., Ltd. (JP) | 1992-08-19 | — | — | EP | disclosed |